Carlos
Roncero Alonso
Profesor Titular de Universidad
Agència de Salut Pública de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Agència de Salut Pública de Barcelona (11)
2019
-
ADGRL3 (LPHN3) variants predict substance use disorder
Translational Psychiatry, Vol. 9, Núm. 1
-
Psychiatric Comorbidity in Treatment-Seeking Alcohol Dependence Patients With and Without ADHD
Journal of Attention Disorders, Vol. 23, Núm. 12, pp. 1497-1504
2018
-
Larger gray matter volume in the basal ganglia of heavy cannabis users detected by voxel-based morphometry and subcortical volumetric analysis
Frontiers in Psychiatry, Vol. 9, Núm. MAY
2017
-
Self-reported daily walking time in COPD: Relationship with relevant clinical and functional characteristics
International Journal of COPD, Vol. 12, pp. 1173-1181
2016
-
Cocaine-induced psychosis and brain-derived neurothrophic factor in patients with cocaine dependence: Report of two cases
Clinical Psychopharmacology and Neuroscience, Vol. 14, Núm. 1, pp. 109-113
-
Diferencias relevantes en la percepción y el grado de conocimiento de los profesionales de las distintas Comunidades Autónomas españolas sobre la existencia de recursos para pacientes con patología dual
Actas Espanolas de Psiquiatria, Vol. 44, Núm. 1, pp. 1-12
-
Professionals’ perception on the management of patients with dual disorders
Patient Preference and Adherence, Vol. 10, pp. 1855-1868
2015
-
Adult ADHD Screening in Alcohol-Dependent Patients Using the Wender–Utah Rating Scale and the Adult ADHD Self-Report Scale
Journal of Attention Disorders, Vol. 19, Núm. 4, pp. 328-334
2014
-
Neuroticism and impulsivity: Their hierarchical organization in the personality characterization of drug-dependent patients from a decision tree learning perspective
Comprehensive Psychiatry, Vol. 55, Núm. 5, pp. 1227-1233
2013
-
Driving and legal status of Spanish opioid-dependent patients
Substance Abuse: Treatment, Prevention, and Policy, Vol. 8, Núm. 1
2012
-
Feasibility of double-blind clinical trials with oral diacetylmorphine: A randomized controlled Phase II study in an inpatient setting
European Addiction Research, Vol. 18, Núm. 6, pp. 279-287